Frequency
Latest
ONXX
Headlines
Here is a list of potential acquisition targets for the world's largest drugmaker.
8:03AM 01/08/09
The trading panel says investors are in for risky market conditions in 2009.
7:25PM 01/05/09
Market and economic turmoil and a new president cloud the forecast for the biotech sector, but investors can make some educated guesses.
12:57PM 12/23/08
China is experiencing huge growth in the pharma/healthcare sector - sparking interest from many global healthcare companies. Paul Boni, Chief Research Officer for Grail Research, breaks down the kind of growth he foresees for big pharmaceutical companies in the coming year thanks to the strong Chinese healthcare market.
06:59AM 12/19/08
Accuray falls 16%.
5:16PM 11/07/08
Senior Columnist Adam Feuerstein re-examines the red flags in the Cell Genesys story so that when the same issues rear their ugly head in another biotech story investors will be better prepared.
10:00AM 10/20/08
Genentech is advancing T-DM1, which uses ImmunoGen technology, into a phase III study as a second-line treatment for Her-2 positive metastatic breast cancer.
11:37AM 10/17/08
Onyx Pharmaceuticals stock deserves to be higher, but the company first needs to better lay out its plans for growth.
11:37AM 10/10/08
The Mad About Options crew reviews Jim Cramer's recent bearish comments about Frontline Ltd. and offers options strategies for traders and investors. Also hear options ideas for Juniper Networks and Onyx Pharmaceuticals.
09:25AM 09/12/08
Cramer says Lehman's CEO had chances to save his company but failed to take any action.
7:44PM 09/09/08
Understanding the Market
Our Experts' Take at RealMoney for ONYX Pharmaceuticals Inc
Traders are cycling back into 'slow motion' stocks and realizing that they oversold Wal-Mart.
12:39PM 01/09/09
Once again, sentiment is in the driver's seat.
8:58AM 01/09/09
More Experts' Takes on ONXX
More popular tickers are indicated by scale.